Dashboard
Manage Tickers

ELDN Eledon Pharmaceuticals, Inc.

Nasdaq https://eledon.com/


$ 2.71 $ -0.01 (-0.37 %)    

Tuesday, 14-Oct-2025 15:59:54 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 598.50 $ -4.01 (-0.67 %)
DIA $ 463.08 $ 2.03 (0.44 %)
SPY $ 662.74 $ -0.81 (-0.12 %)
TLT $ 90.69 $ 0.29 (0.32 %)
GLD $ 382.95 $ 2.70 (0.71 %)
$ 2.71
$ 2.67
$ 2.55 x 500
$ 2.78 x 100
$ 2.58 - $ 2.75
$ 2.32 - $ 5.54
597,597
na
162.28M
$ 0.21
$ 11.08
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-14-2025 06-30-2025 10-Q
2 05-14-2025 03-31-2025 10-Q
3 03-20-2025 12-31-2024 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-19-2024 06-30-2024 10-Q
6 05-15-2024 03-31-2024 10-Q
7 03-28-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-10-2023 06-30-2023 10-Q
10 05-11-2023 03-31-2023 10-Q
11 03-30-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-11-2022 06-30-2022 10-Q
14 05-12-2022 03-31-2022 10-Q
15 03-24-2022 12-31-2021 10-K
16 11-12-2021 09-30-2021 10-Q
17 08-12-2021 06-30-2021 10-Q
18 05-14-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
20 11-16-2020 09-30-2020 10-Q
21 08-14-2020 06-30-2020 10-Q
22 05-15-2020 03-31-2020 10-Q
23 03-17-2020 12-31-2019 10-K
24 11-13-2019 09-30-2019 10-Q
25 08-13-2019 06-30-2019 10-Q
26 05-14-2019 03-31-2019 10-Q
27 03-28-2019 12-31-2018 10-K
28 11-13-2018 09-30-2018 10-Q
29 08-07-2018 06-30-2018 10-Q
30 05-11-2018 03-31-2018 10-Q
31 04-02-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-03-2017 03-31-2017 10-Q
35 03-03-2017 12-31-2016 10-K
36 11-03-2016 09-30-2016 10-Q
37 08-04-2016 06-30-2016 10-Q
38 05-10-2016 03-31-2016 10-Q
39 03-10-2016 12-31-2015 10-K
40 11-10-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

hc-wainwright--co-reiterates-buy-on-eledon-pharmaceuticals-maintains-9-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
09/02/2025 11:05:30

HC Wainwright & Co. analyst Yi Chen reiterates Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy and maintains $9 price ta...

eledon-pharma-q2-eps-013-beats-024-estimate
Eledon Pharma Q2 EPS $(0.13) Beats $(0.24)...
08/14/2025 20:45:02

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.24)...

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 17:09:32

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
08/07/2025 12:07:31

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
08/06/2025 21:07:28

voyager-eledon-presents-data-from-phase-1b-trial-evaluating-tegoprubart-for-prevention-of-rejection-in-kidney-transplant-patients
Voyager Eledon Presents Data From Phase 1b...
08/06/2025 20:54:31

Data from patients who remained on tegoprubart for a year showed overall mean 12-month eGFR of approximately 68 mL/min/1.73 m² ...

eledon-pharmaceutical-to-host-a-conference-call-and-webcast-on-wednesday-august-6-2025-to-discuss-updated-clinical-data-from-its-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-the-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation
Eledon Pharmaceutical To Host A Conference...
07/30/2025 20:30:50

IRVINE, Calif., July 30, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. ("Eledon") (NASDAQ:ELDN) today announced...

Core News & Articles
12 Health Care Stocks Moving In Monday's A...
07/28/2025 21:05:57

craig-hallum-initiates-coverage-on-eledon-pharmaceuticals-with-buy-rating-announces-price-target-of-12
Craig-Hallum Initiates Coverage On Eledon ...
07/25/2025 17:54:47

Craig-Hallum initiates coverage on Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price Target of $12.

eledon-pharma-to-present-updated-clinical-data-from-ongoing-open-label-phase-1b-study-evaluating-tegoprubart-for-prevention-of-rejection-in-subjects-undergoing-kidney-transplantation-at-wtc-2025
Eledon Pharma To Present Updated Clinical ...
07/17/2025 20:03:14

Core News & Articles
Eledon And Sernova Collaborate To Test Teg...
07/09/2025 12:36:02

Sernova Biotherapeutics ("Sernova") (TSX:SVA) (OTCQB:SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research A...

hc-wainwright--co-assumes-eledon-pharmaceuticals-at-buy-announces-price-target-of-9
HC Wainwright & Co. Assumes Eledon Pharmac...
06/18/2025 11:38:13

HC Wainwright & Co. analyst Yi Chen assumes Eledon Pharmaceuticals (NASDAQ:ELDN) with a Buy rating and announces Price T...

eledon-pharma-q1-eps-008-beats-030-estimate
Eledon Pharma Q1 EPS $(0.08) Beats $(0.30)...
05/14/2025 20:22:02

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.08) per share which beat the analyst consensus estimate of $(0.30)...

eledon-pharma-fy-2024-gaap-eps-075-misses-064-estimate
Eledon Pharma FY 2024 GAAP EPS $(0.75) Mis...
03/20/2025 20:11:34

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.6...

hc-wainwright--co-reiterates-buy-on-eledon-pharma-maintains-16-price-target
HC Wainwright & Co. Reiterates Buy on Eled...
11/20/2024 13:17:52

HC Wainwright & Co. analyst Vernon Bernardino reiterates Eledon Pharma (NASDAQ:ELDN) with a Buy and maintains $16 price ...

eledon-pharma-q3-eps-032-misses-030-estimate
Eledon Pharma Q3 EPS $(0.32) Misses $(0.30...
11/12/2024 21:42:26

Eledon Pharma (NASDAQ:ELDN) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.3...

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
10/30/2024 20:31:02

eledon-pharmaceuticals-has-priced-its-underwritten-offering-of-184m-shares-at-365share-and-pre-funded-warrants-to-purchase-up-to-49m-shares-at-3649pre-funded-warrant-with-gross-proceeds-of-approximately-85m
Eledon Pharmaceuticals Has Priced Its Unde...
10/29/2024 11:59:06

eledon-pharmaceuticals-announced-data-for-the-first-three-islet-transplant-recipients-treated-with-an-immunosuppression-regimen-that-includes-tegoprubart-to-prevent-islet-transplant-rejection-in-subjects-with-type-1-diabetes
Eledon Pharmaceuticals Announced Data For ...
10/29/2024 11:47:05

First two out of three subjects treated with tegoprubart as part of immunosuppression regimen to prevent transplant rejection a...

eledon-pharmaceuticals-announced-that-it-has-successfully-completed-enrollment-for-its-phase-2-bestow-clinical-trial-for-prevention-of-organ-rejection-in-kidney-transplant-patients
Eledon Pharmaceuticals Announced That It H...
09/04/2024 11:10:23

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION